Another State Sues Pfizer

Maryanne DemasiBy: Maryanne Demasi

Kansas is the latest US state to file a lawsuit against Pfizer, accusing the pharmaceutical giant of misleading the public about the safety and effectiveness of its Covid-19 vaccine.

Kansas Attorney General Kris Kobach claims that Pfizer knew about the risks associated with its vaccine, “including myocarditis and pericarditis, failed pregnancies, and deaths” but failed to disclose this information to the public.

                   Kris Kobach, Attorney General of Kansas (Original article)

The 179-page lawsuit also alleges that Pfizer made ‘false and misleading’ statements regarding the vaccine’s ability to prevent viral transmission, its waning effectiveness, and its ability to protect against new variants of the virus.

To keep the public from learning the truth, Pfizer worked to censor speech on social media that questioned Pfizer’s claims about its Covid-19 vaccine,” alleges the lawsuit.

Kansas asserts that Pfizer’s “misrepresentations” violated the state’s Consumer Protection Act, as well as the ability of its citizens to give informed consent when deciding to “receive or forgo” Pfizer’s shot, and therefore is seeking $20,000 in damages for each violation.

Kobach wants Pfizer to be held accountable for “falsely representing the benefits” of its vaccine and “concealing and suppressing the truth” about its harms.

Regular readers of this publication might recall that a similar case was filed by Texas Attorney General Ken Paxton last year, which also alleges that Pfizer misled the public about the effectiveness of its Covid-19 vaccine – a lawsuit which is still pending.

The bottom line is that none of the allegations in either lawsuit should come as a surprise.

Many subscribers who’ve been with me since the beginning of the pandemic understood that rushing an experimental vaccine through clinical trials would spell danger for trust in other vaccines and compromise the collection of harms data.

When Pfizer finally published its clinical trial data, it became evident the company was grossly exaggerating the benefits, and underplaying the harms.

Pfizer and health authorities worked hard to keep myocarditis cases under wraps just as early data showed myocarditis was occurring more commonly in younger men (16-19 years), particularly after the second dose, at a rate of 1 in 6,600.

Regulatory filings showed that Pfizer knew its vaccine effectiveness waned quickly, but waited months before alerting the public.

Pregnant women were excluded from the original trials and when the public raised hell about the lack of data, Pfizer commenced a trial in 2021. It was later abandoned because enrollment into the study “declined significantly.”

Many months later, when Pfizer published what little data it had in pregnant women, it was clear the trial was under-powered, poorly designed, and insufficient to vouch for the vaccine’s safety in pregnancy.

Now, Pfizer will be forced to confront the evidence against it.

In response to the latest lawsuit, Pfizer maintains it is “deeply committed to the well-being of the patients it serves and has no higher priority than ensuring the safety and effectiveness of its treatments and vaccines.”

Hopefully, the actions of Kansas and Texas will encourage lawmakers in other US states to file their own lawsuits if there is any chance of restoring public trust in Pfizer.


This article (Another State Sues Pfizer) was  published on the BROWNSTONE INSTITUTE and is republished here (on TLB) with permission and attribution to the author Maryanne Demasi and

About the Author: Maryanne Demasi, 2023 Brownstone Fellow, is an investigative medical reporter with a PhD in rheumatology, who writes for online media and top tiered medical journals. For over a decade, she produced TV documentaries for the Australian Broadcasting Corporation (ABC) and has worked as a speechwriter and political advisor for the South Australian Science Minister.

This Article originated on the author’s Substack.

Image Credit: Photo (cropped) in Featured Image (top) – by Mike Ramírez Mx from Pixabay


The Liberty Beacon Project is now expanding at a near exponential rate, and for this we are grateful and excited! But we must also be practical. For 7 years we have not asked for any donations, and have built this project with our own funds as we grew. We are now experiencing ever increasing growing pains due to the large number of websites and projects we represent. So we have just installed donation buttons on our websites and ask that you consider this when you visit them. Nothing is too small. We thank you for all your support and your considerations … (TLB)


Comment Policy: As a privately owned web site, we reserve the right to remove comments that contain spam, advertising, vulgarity, threats of violence, racism, or personal/abusive attacks on other users. This also applies to trolling, the use of more than one alias, or just intentional mischief. Enforcement of this policy is at the discretion of this websites administrators. Repeat offenders may be blocked or permanently banned without prior warning.


Disclaimer: TLB websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.


Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.

Be the first to comment

Leave a Reply

Your email address will not be published.